C4 Therapeutics, Inc.
CCCC
$2.61
-$0.08-2.97%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 248.54M | 191.88M | 214.55M | 215.09M | 244.90M |
| Total Receivables | 2.40M | 6.54M | 2.16M | 8.03M | 3.10M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.17M | 8.44M | 8.02M | 9.42M | 9.76M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 258.11M | 206.86M | 224.73M | 232.54M | 257.77M |
|
|
|||||
| Total Current Assets | 258.11M | 206.86M | 224.73M | 232.54M | 257.77M |
| Net Property, Plant & Equipment | 45.28M | 47.10M | 59.76M | 61.36M | 63.38M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 7.13M | 3.65M | 3.62M | 6.01M | 6.10M |
| Total Assets | 359.08M | 265.49M | 296.53M | 319.52M | 349.60M |
|
|
|||||
| Total Accounts Payable | 858.00K | 1.33M | 2.22M | 683.00K | 1.33M |
| Total Accrued Expenses | 11.92M | 9.52M | 11.98M | 10.75M | 17.49M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.37M | 6.22M | 6.07M | 5.92M | 5.77M |
| Total Finance Division Other Current Liabilities | 13.89M | 18.88M | 24.20M | 23.47M | 20.58M |
| Total Other Current Liabilities | 13.89M | 18.88M | 24.20M | 23.47M | 20.58M |
| Total Current Liabilities | 33.03M | 35.95M | 44.46M | 40.82M | 45.18M |
|
|
|||||
| Total Current Liabilities | 33.03M | 35.95M | 44.46M | 40.82M | 45.18M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 53.62M | 55.25M | 56.86M | 58.45M | 59.98M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.84M | 19.89M | 21.15M | 25.12M | 28.46M |
| Total Liabilities | 102.49M | 111.08M | 122.46M | 124.38M | 133.62M |
|
|
|||||
| Common Stock & APIC | 995.23M | 872.53M | 860.14M | 855.12M | 849.63M |
| Retained Earnings | -738.69M | -718.21M | -686.04M | -660.02M | -633.70M |
| Treasury Stock & Other | 50.00K | 87.00K | -30.00K | 43.00K | 53.00K |
| Total Common Equity | 256.59M | 154.41M | 174.06M | 195.14M | 215.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 256.59M | 154.41M | 174.06M | 195.14M | 215.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 256.59M | 154.41M | 174.06M | 195.14M | 215.99M |
|
|
|||||